Emerald Clinical Trial’s team of renal experts will be attending the 63rd Annual ERA Congress 2026
Schedule a Meeting at Booth A.310
Optimizing Renal Clinical Trials: Integrating Science, Regulation, and Care
The ERA 2026 theme, “Challenge Your Thinking,” aligns perfectly with Emerald Clinical’s mission to de-risk complex renal drug development. Our advisory board bridges the gap between drug developers and nephrologists to align scientific innovation with regulatory and clinical practicality, optimizing trial design from the start. By translating this alignment into expert guidance, the team ensures endpoint selection and biomarker validation are both defensible to regulators and valuable to clinicians and patients.
Emerald Clinical: Where Developers and Nephrologists Converge
We don’t just follow protocols; we help shape the market through:
- Renal Advisory Board: Leverage the strategic clarity of world-renowned nephrologists like Prof. Jonathan Barratt and Prof. David Wheeler.
- Global Reach, Local Insight: Access to 90+ renal experts across the US, Europe, APAC, and LATAM, and on-the-ground teams in 40+ locations.
- Deep Therapeutic Expertise: Proven success in complex trials for IgA Nephropathy (IgAN), CKD, FSGS, and Acute Kidney Injury.
- Patient-Centricity: Integrating real-world clinical insight grounded in daily patient care to optimize trial endpoints and recruitment.
Are you ready to accelerate your clinical pathway? Secure a meeting with the Emerald Clinical team during ERA 2026 to discuss:
- Smarter Trial Design: From preclinical planning to pivotal Phase III trials.
- Regulatory Navigation: Aligning with evolving standards and in-country compliance.
- Rapid Recruitment: Leveraging our unique site alliances to reach diverse patient populations.
How we have helped our clients
Contact us to schedule a 1-on-1 session at the congress or visit us at booth A.310
Meet our Team
Learn more about our Renal capabilities
Molly Bur Kitten
David Cass
Oz Sahin
Doug Hartenstein
